David Pittman of Medpagetoday.com reports that the Institute of Medicine (IOM) applauded the NIH’s Clinical and Translational Science Awards (CTSA) Program and its significance to the advancement of clinical and translational research. The CTSA program was created to...
On August 8, 2013, Gretchen Bowker, co-founder and COO of Pearl Pathways, will host a webinar on ComplianceOnline.com reviewing the similarities and differences in the regulatory paths and requirements for drugs, biologics and medical devices. It will discuss the...
Do you work at a site as a clinical research coordinator and need a deeper dive into Good Clinical Practices (GCPs)? Are you a sponsor who has responsibility for oversight and training of site personnel? On July 26, 2013, Pearl Pathways’ own Ellen Looney will lead a...
Are you a supplier of raw materials, component parts or finished product to biopharma or medical device companies? The supply chain for pharmaceuticals, biologics and medical device companies are increasingly being audited by their clients and FDA. On July 25, 2013,...
An article posted on clindev.eu shares that the European Medicines Agency (EMA) has announced a three month public consultation of a draft transparency policy regarding clinical trial information. EMA is hoping to launch the policy in early 2014. Potential threats to...
